Heavily pretreated patient with nodal marginal zone lymphoma successfully treated with mosunetuzumab.

Lucijanic, Marko; Sabljic, Anica; Vlasac Glasnovic, Josipa; Soric, Ena; Jonjic, Zeljko; Kusec, Rajko

Lucijanic, Marko; Sabljic, Anica; Vlasac Glasnovic, Josipa; Soric, Ena; Jonjic, Zeljko; Kusec, Rajko.

Afiliación

Lucijanic M; Hematology Department, University hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia. markolucijanic@yahoo.com.
Sabljic A; Internal Medicine Department, School of Medicine University of Zagreb, Salata 3, 10000, Zagreb, Croatia. markolucijanic@yahoo.com.
Vlasac Glasnovic J; Hematology Department, University hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.
Soric E; Hematology Department, University hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.
Jonjic Z; Hematology Department, University hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.
Kusec R; Hematology Department, University hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.

Ann Hematol ; 103(3): 1015-1016, 2024 Mar.

Article en En | MEDLINE | ID: mdl-38006570

Asunto(s)

Antineoplásicos; Linfoma de Células B de la Zona Marginal; Humanos; Linfoma de Células B de la Zona Marginal/patología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B de la Zona Marginal / Antineoplásicos Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Croacia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google